| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-09 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
1e-08 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-07 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
| mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-07 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-06 |